Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction

Biomaterials

Volumn 105, Issue , 2016, Pages 52-65

  Wang, Qingjie ^a   Yang, Hui ^a   Bai, Aobing ^a   Jiang, Wei ^a   Li, Xiuya ^a   Wang, Xinhong ^a   Mao, Yishen ^a   Lu, Chao ^a   Qian, Ruizhe ^a   Guo, Feng ^a   Ding, Tianling ^b   Chen, Haiyan ^a   Chen, Sifeng ^a   Zhang, Jianyi ^c   Liu, Chen ^a   Sun, Ning ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cardiac patch; Cardiomyocytes; Decellularized heart matrix; Engineering human heart tissue; Induced pluripotent stem cells; Myocardial infarction

Indexed keywords

CARDIOLOGY; CELL ENGINEERING; CELLS; CYTOLOGY; DIAGNOSIS; DISEASE CONTROL; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE; TISSUE ENGINEERING;

CARDIAC PATCH; CARDIOMYOCYTES; DECELLULARIZED; HUMAN HEART; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL INFARCTION;

HEART;

ACUTE HEART INFARCTION; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; ENGINEERED HEART TISSUE; EXTRACELLULAR MATRIX; HEART ELECTROPHYSIOLOGY; HEART FIBROBLAST; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; INTRACARDIAC PATCH; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SCAFFOLD; ACUTE DISEASE; ANIMAL; CELL DIFFERENTIATION; CELL FREE SYSTEM; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DEVICES; FIBROBLAST; HEART INFARCTION; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING; TRANSPLANTATION; TREATMENT OUTCOME;

ACUTE DISEASE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL-FREE SYSTEM; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TREATMENT OUTCOME;

EID: 84982812300     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.07.035     Document Type: Article

References (37)

1. [1] Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B., C. American heart association statistics, S. Stroke statistics. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127:1 (2013), e6–e245.
2. [2] McMurray, J.J., Pfeffer, M.A., Heart failure. Lancet 365:9474 (2005), 1877–1889.
3. [3] Vunjak Novakovic, G., Eschenhagen, T., Mummery, C., Myocardial tissue engineering: in vitro models. Cold Spring Harb. Perspect. Med., 4(3), 2014.
4. [4] Hirt, M.N., Hansen, A., Eschenhagen, T., Cardiac tissue engineering: state of the art. Circ. Res. 114:2 (2014), 354–367.
5. [5] Tulloch, N.L., Muskheli, V., Razumova, M.V., Korte, F.S., Regnier, M., Hauch, K.D., Pabon, L., Reinecke, H., Murry, C.E., Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ. Res. 109:1 (2011), 47–59.
6. [6] Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., Kawamura, T., Kuratani, T., Daimon, T., Shimizu, T., Okano, T., Sawa, Y., Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126:11 Suppl 1 (2012), S29–S37.
7. [7] Ye, L., Chang, Y.H., Xiong, Q., Zhang, P., Zhang, L., Somasundaram, P., Lepley, M., Swingen, C., Su, L., Wendel, J.S., Guo, J., Jang, A., Rosenbush, D., Greder, L., Dutton, J.R., Zhang, J., Kamp, T.J., Kaufman, D.S., Ge, Y., Zhang, J., Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15:6 (2014), 750–761.
8. [8] Ye, L., Zimmermann, W.H., Garry, D.J., Zhang, J., Patching the heart: cardiac repair from within and outside. Circ. Res. 113:7 (2013), 922–932.
9. [9] Yasui, H., Lee, J.K., Yoshida, A., Yokoyama, T., Nakanishi, H., Miwa, K., Naito, A.T., Oka, T., Akazawa, H., Nakai, J., Miyagawa, S., Sawa, Y., Sakata, Y., Komuro, I., Excitation propagation in three-dimensional engineered hearts using decellularized extracellular matrix. Biomaterials 35:27 (2014), 7839–7850.
10. [10] Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., Taylor, D.A., Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14:2 (2008), 213–221.
11. [11] Lu, T.Y., Lin, B., Kim, J., Sullivan, M., Tobita, K., Salama, G., Yang, L., Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat. Commun., 4, 2013, 2307.
12. [12] Xin, M., Olson, E.N., Bassel-Duby, R., Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat. Rev. Mol. Cell Biol. 14:8 (2013), 529–541.
13. [13] Guyette, J.P., Charest, J.M., Mills, R.W., Jank, B.J., Moser, P.T., Gilpin, S.E., Gershlak, J.R., Okamoto, T., Gonzalez, G., Milan, D.J., Gaudette, G.R., Ott, H.C., Bioengineering human myocardium on native extracellular matrix. Circ. Res. 118:1 (2016), 56–72.
14. [14] Sun, N., Panetta, N.J., Gupta, D.M., Wilson, K.D., Lee, A., Jia, F., Hu, S., Cherry, A.M., Robbins, R.C., Longaker, M.T., Wu, J.C., Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. U. S. A. 106:37 (2009), 15720–15725.
15. [15] Lian, X., Zhang, J., Azarin, S.M., Zhu, K., Hazeltine, L.B., Bao, X., Hsiao, C., Kamp, T.J., Palecek, S.P., Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/beta-catenin signaling under fully defined conditions. Nat. Protoc. 8:1 (2013), 162–175.
16. [16] Zhu, W.Z., Van Biber, B., Laflamme, M.A., Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods Mol. Biol. 767 (2011), 419–431.
17. [17] Kehat, I., Gepstein, A., Spira, A., Itskovitz-Eldor, J., Gepstein, L., High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ. Res. 91:8 (2002), 659–661.
18. [18] Feld, Y., Melamed-Frank, M., Kehat, I., Tal, D., Marom, S., Gepstein, L., Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation 105:4 (2002), 522–529.
19. [19] Kehat, I., Khimovich, L., Caspi, O., Gepstein, A., Shofti, R., Arbel, G., Huber, I., Satin, J., Itskovitz-Eldor, J., Gepstein, L., Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22:10 (2004), 1282–1289.
20. [20] Huber, B.C., Ransohoff, J.D., Ransohoff, K.J., Riegler, J., Ebert, A., Kodo, K., Gong, Y., Sanchez-Freire, V., Dey, D., Kooreman, N.G., Diecke, S., Zhang, W.Y., Odegaard, J., Hu, S., Gold, J.D., Robbins, R.C., Wu, J.C., Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation. Stem Cells 31:11 (2013), 2354–2363.
21. [21] Sekine, H., Shimizu, T., Hobo, K., Sekiya, S., Yang, J., Yamato, M., Kurosawa, H., Kobayashi, E., Okano, T., Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118:14 Suppl (2008), S145–S152.
22. [22] Ong, S.G., Huber, B.C., Lee, W.H., Kodo, K., Ebert, A.D., Ma, Y., Nguyen, P.K., Diecke, S., Chen, W.Y., Wu, J.C., Microfluidic single-cell analysis of transplanted human induced pluripotent stem cell-derived cardiomyocytes after acute myocardial infarction. Circulation 132:8 (2015), 762–771.
23. [23] Xiong, Q., Ye, L., Zhang, P., Lepley, M., Swingen, C., Zhang, L., Kaufman, D.S., Zhang, J., Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circ. Res. 111:4 (2012), 455–468.
24. [24] Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O.J., Navarrete, E.G., Hu, S., Wang, L., Lee, A., Pavlovic, A., Lin, S., Chen, R., Hajjar, R.J., Snyder, M.P., Dolmetsch, R.E., Butte, M.J., Ashley, E.A., Longaker, M.T., Robbins, R.C., Wu, J.C., Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med., 4(130), 2012, 130ra47.
25. [25] Iyer, R.K., Odedra, D., Chiu, L.L., Vunjak-Novakovic, G., Radisic, M., Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids. Tissue Eng. Part A 18:17–18 (2012), 1771–1783.
26. [26] Thavandiran, N., Dubois, N., Mikryukov, A., Masse, S., Beca, B., Simmons, C.A., Deshpande, V.S., McGarry, J.P., Chen, C.S., Nanthakumar, K., Keller, G.M., Radisic, M., Zandstra, P.W., Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc. Natl. Acad. Sci. U. S. A. 110:49 (2013), E4698–E4707.
27. [27] Higuchi, S., Lin, Q., Wang, J., Lim, T.K., Joshi, S.B., Anand, G.S., Chung, M.C., Sheetz, M.P., Fujita, H., Heart extracellular matrix supports cardiomyocyte differentiation of mouse embryonic stem cells. J. Biosci. Bioeng. 115:3 (2013), 320–325.
28. [28] Little, C.D., Rongish, B.J., The extracellular matrix during heart development. Experientia 51:9–10 (1995), 873–882.
29. [29] Zhang, L., Guo, J., Zhang, P., Xiong, Q., Wu, S.C., Xia, L., Roy, S.S., Tolar, J., O'Connell, T.D., Kyba, M., Liao, K., Zhang, J., Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast. Circ. Heart Fail 8:1 (2015), 156–166.
30. [30] Burnette, M., Brito-Robinson, T., Li, J., Zartman, J., An inverse small molecule screen to design a chemically defined medium supporting long-term growth of Drosophila cell lines. Mol. Biosyst. 10:10 (2014), 2713–2723.
31. [31] Ma, Z., Yang, H., Liu, H., Xu, M., Runyan, R.B., Eisenberg, C.A., Markwald, R.R., Borg, T.K., Gao, B.Z., Mesenchymal stem cell-cardiomyocyte interactions under defined contact modes on laser-patterned biochips. Plos One, 8(2), 2013, e56554.
32. [32] McSpadden, L.C., Nguyen, H., Bursac, N., Size and ionic currents of unexcitable cells coupled to cardiomyocytes distinctly modulate cardiac action potential shape and pacemaking activity in micropatterned cell pairs. Circ. Arrhythm. Electrophysiol. 5:4 (2012), 821–830.
33. [33] Bradley, J.E., Ramirez, G., Hagood, J.S., Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype. Biofactors 35:3 (2009), 258–265.
34. [34] Seif-Naraghi, S.B., Singelyn, J.M., Salvatore, M.A., Osborn, K.G., Wang, J.J., Sampat, U., Kwan, O.L., Strachan, G.M., Wong, J., Schup-Magoffin, P.J., Braden, R.L., Bartels, K., DeQuach, J.A., Preul, M., Kinsey, A.M., DeMaria, A.N., Dib, N., Christman, K.L., Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci. Transl. Med., 5(173), 2013, 173ra25.
35. [35] Shudo, Y., Cohen, J.E., MacArthur, J.W., Goldstone, A.B., Otsuru, S., Trubelja, A., Patel, J., Edwards, B.B., Hung, G., Fairman, A.S., Brusalis, C., Hiesinger, W., Atluri, P., Hiraoka, A., Miyagawa, S., Sawa, Y., Woo, Y.J., A tissue-engineered chondrocyte cell sheet induces extracellular matrix modification to enhance ventricular biomechanics and attenuate myocardial stiffness in ischemic cardiomyopathy. Tissue Eng. Part A 21:19–20 (2015), 2515–2525.
36. [36] Godier-Furnemont, A.F., Martens, T.P., Koeckert, M.S., Wan, L., Parks, J., Arai, K., Zhang, G., Hudson, B., Homma, S., Vunjak-Novakovic, G., Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Natl. Acad. Sci. U. S. A. 108:19 (2011), 7974–7979.
37. [37] Passier, R., van Laake, L.W., Mummery, C.L., Stem-cell-based therapy and lessons from the heart. Nature 453:7193 (2008), 322–329.